Biotechnology has been a significant differentiator for Wockhardt. It has set us apart, helped us blaze new paths, and set goals that have impacted health and redesigned our future.

Much ahead of time, Wockhardt anticipated the potential of biotechnology as the ‘Science of the Future’, and started preparing well in advance of its peers.

Wockhardt’s biotechnology programme has been geared towards a single objective -- making high-quality affordable products that will bring the benefits of this amazing science to a large section of patients.

With nearly a decade of experience in mastering biotechnology research, Wockhardt has built a competent organisation of skilled biotechnologists and ‘concept to market’ capabilities in all facets of development and manufacture of recombinant biopharmaceuticals.

Wockhardt’s comprehensive capabilities in biotechnology include:

Gene cloning, Development of production strains, Expression of proteins in all major expression systems -- yeast, mammalian and bacterial cells, Purification, Downstream processing and development, Testing, Marketing of formulations.